Pelvic Inflammatory Disease: Diagnosis and Treatment Essay

Diagnosis

Differential Diagnoses

• Pelvic inflammatory disease is one of the disorders that might be affecting the patient. Udoji and Ness (2018) state that “painful urination is one of the common symptoms” of the pelvic inflammatory disease. While not all the symptoms are present, it is a definite differential diagnosis of the patient’s condition.
• Candidiasis may also affect the vaginal area of the patient and present several negative outcomes similar to those of Chlamydia. A paper from Arendrup et al. (2018) states that candidiasis is a “relatively rare” condition. The symptoms of the infection are described similarly, but due to the rarity of the condition and lack of bodily discharge, it is only a differential diagnosis.
• Trichomoniasis is another condition that might have a similar effect on the patient. Kissinger (2015) states that “Trichomonas vaginosis is the most common nonviral sexually transmitted infection” and examines several situations where patients experienced conditions that could be similar to chlamydia. However, the nature of the infection and previous history of the patient suggests that this could not be the final verdict.

Diagnosis

• Hypertension is secondary to chlamydial infections. Subjective evidence of recent treatments for chlamydia shows that any complaints related to the genital area that the patient may or may not experience are likely to be caused by this condition is not fully treated. While the objective evidence reports no painful bodily functions, they may once more if the treatment is not finished. History of hypertension also suggests that the patient should be aware of the possibility of developing it.

Plan/Therapeutics

• The patient was subjected to an ordered laboratory dipstick test. The results are supposed to be followed up by the patient and take recommendations provided on the treatment schedule per se by the consultants in the respective fields. The patient was advised to follow up on the treatment of hypertension. She needs monthly review to check on the blood pressure, by this, she will be able to commence the management of hypertension that she had reported.
• If the tests confirm that the condition is still present in the patient a course of treatment should be prepared. Medication for the treatment should include a 100mg dose of Vibramycin or a similar antibiotic over at least seven days. Side effects of Vibramycin include a variety of gastrointestinal conditions such as the upset stomach, nausea, and vomiting. It is important to note that Vibramycin is a doxycycline drug. One of its effects is the increase of pressure inside the skull. Due to the patient’s possible hypertension, it is crucial to warn the patient that if side effects such as severe headaches or changes in vision occur, she must stop taking the drug immediately and report back for further examination. If the test results confirm the presence of hypertension, treatment should be prescribed. Hypertension is a relatively common condition that makes its presence likely. The treatment should include 12.5 to 25 mg of Chlorthalidone and ACE inhibitors taken to lower the blood pressure of the patient. Their side effects may include dry mouth, thirst, vomiting, nausea, muscle pain, weakness, uneven heartbeats, fatigue, dizziness, headaches, loss of taste, and the increased level of blood-potassium. Treatment should not coincide with chlamydia treatment because of the possible confusion between the side effects. Hypertension may result in highly negative outcomes for the patient if skull pressure side effects are not identified immediately.
• The patient should be educated on the possible early symptoms of her condition, as well as ways to prevent it from happening in the future. The patient should also be educated on the risks that her condition is associated with and how she may improve it through nonmedical conditions.
• They may include dieting and exercise routines designed to improve the condition of the patient’s cardiovascular system (Geisler, 2015). Additional hygiene products may be introduced into the patient’s shower routine to provide a nonmedication treatment for the disease.

References

Arendrup, M. C., Boekhout, T., Akova, M., Meis, J. F., Cornely, O. A., & Lortholary, O. (2014). ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clinical Microbiology and Infection, 20, 76–98.

Geisler, W. M. (2015). Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: Summary of evidence reviewed for the 2015 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Clinical Infectious Diseases, 61, 774–784.

Kissinger, P. (2015). Epidemiology and treatment of trichomoniasis. Current Infectious Disease Reports, 17(6), 31.

Udoji, M. A., & Ness, T. J. (2018). Urogenital and pelvic pain. In Fundamentals of Pain Medicine (pp. 271–278). Cham, Switzerland: Springer, Cham.